Skip to main content

Table 3 Overall response rate

From: Changing monoclonal antibody keeping unaltered the chemotherapy regimen in metastatic colorectal cancer patients: is efficacy maintained?

 

First line

Second line

 

N. (%)

N. (%)

Best    Overall Response

22 (44.5)

12 (22.2)*

     Complete Response

5 (9.3)

0 (0)

     Partial Response

19 (35.2)

12 (22.2)

     Stable Disease

22(40.7)

23 (46.2)

     Progressive Disease

8 (14.8)

19 (35.2)

Disease Control Rate

44 (81.5)

35 (64.8)**

* CI 95% 11.1-33.3

  

**CI 95% 52.1-77.5